234 related articles for article (PubMed ID: 35441886)
1. An approach to p32/gC1qR/HABP1: a multifunctional protein with an essential role in cancer.
Egusquiza-Alvarez CA; Robles-Flores M
J Cancer Res Clin Oncol; 2022 Aug; 148(8):1831-1854. PubMed ID: 35441886
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Multifunctional Protein p32/C1QBP Promotes Cytostatic Effects in Colon Cancer Cells by Altering Mitogenic Signaling Pathways and Promoting Mitochondrial Damage.
Egusquiza-Alvarez CA; Moreno-Londoño AP; Alvarado-Ortiz E; Ramos-Godínez MDP; Sarabia-Sánchez MA; Castañeda-Patlán MC; Robles-Flores M
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473963
[TBL] [Abstract][Full Text] [Related]
3. Complement protein C1q stimulates hyaluronic acid degradation
Balduit A; Vidergar R; Zacchi P; Mangogna A; Agostinis C; Grandolfo M; Bottin C; Salton F; Confalonieri P; Rocca A; Zanconati F; Confalonieri M; Kishore U; Ghebrehiwet B; Bulla R
Front Immunol; 2023; 14():1151194. PubMed ID: 37334363
[TBL] [Abstract][Full Text] [Related]
4. Role of C1QBP/p32 and its Therapeutic Potential in Breast Carcinoma and other Cancers.
Matsumoto K; Bay BH
Curr Med Chem; 2021; 28(25):5048-5065. PubMed ID: 33390103
[TBL] [Abstract][Full Text] [Related]
5. Multi-functional, multicompartmental hyaluronan-binding protein 1 (HABP1/p32/gC1qR): implication in cancer progression and metastasis.
Saha P; Datta K
Oncotarget; 2018 Feb; 9(12):10784-10807. PubMed ID: 29535843
[TBL] [Abstract][Full Text] [Related]
6. gC1qR: A New Target for Cancer Immunotherapy.
Lei Y; Li X; Qin D; Zhang Y; Wang Y
Front Immunol; 2023; 14():1095943. PubMed ID: 36776869
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial p32 protein is a critical regulator of tumor metabolism via maintenance of oxidative phosphorylation.
Fogal V; Richardson AD; Karmali PP; Scheffler IE; Smith JW; Ruoslahti E
Mol Cell Biol; 2010 Mar; 30(6):1303-18. PubMed ID: 20100866
[TBL] [Abstract][Full Text] [Related]
8. The C1q and gC1qR axis as a novel checkpoint inhibitor in cancer.
Ghebrehiwet B; Zaniewski M; Fernandez A; DiGiovanni M; Reyes TN; Ji P; Savitt AG; Williams JL; Seeliger MA; Peerschke EIB
Front Immunol; 2024; 15():1351656. PubMed ID: 38711524
[TBL] [Abstract][Full Text] [Related]
9. The C1q Receptors: Focus on gC1qR/p33 (C1qBP, p32, HABP-1)
Ghebrehiwet B; Geisbrecht BV; Xu X; Savitt AG; Peerschke EIB
Semin Immunol; 2019 Oct; 45():101338. PubMed ID: 31744753
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronan-binding protein 1 (HABP1/p32/gC1qR) induces melanoma cell migration and tumor growth by NF-kappa B dependent MMP-2 activation through integrin α(v)β(3) interaction.
Prakash M; Kale S; Ghosh I; Kundu GC; Datta K
Cell Signal; 2011 Oct; 23(10):1563-77. PubMed ID: 21627988
[TBL] [Abstract][Full Text] [Related]
11. gC1qR/HABP1/p32 Is a Potential New Therapeutic Target Against Mesothelioma.
Peerschke E; Stier K; Li X; Kandov E; de Stanchina E; Chang Q; Xiong Y; Manova-Todorova K; Fan N; Barlas A; Ghebrehiwet B; Adusumilli PS
Front Oncol; 2020; 10():1413. PubMed ID: 32903438
[TBL] [Abstract][Full Text] [Related]
12. p32 protein levels are integral to mitochondrial and endoplasmic reticulum morphology, cell metabolism and survival.
Hu M; Crawford SA; Henstridge DC; Ng IH; Boey EJ; Xu Y; Febbraio MA; Jans DA; Bogoyevitch MA
Biochem J; 2013 Aug; 453(3):381-91. PubMed ID: 23692256
[TBL] [Abstract][Full Text] [Related]
13. Loss of Mucosal p32/gC1qR/HABP1 Triggers Energy Deficiency and Impairs Goblet Cell Differentiation in Ulcerative Colitis.
Sünderhauf A; Hicken M; Schlichting H; Skibbe K; Ragab M; Raschdorf A; Hirose M; Schäffler H; Bokemeyer A; Bettenworth D; Savitt AG; Perner S; Ibrahim S; Peerschke EI; Ghebrehiwet B; Derer S; Sina C
Cell Mol Gastroenterol Hepatol; 2021; 12(1):229-250. PubMed ID: 33515804
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of hyaluronan-binding protein 1 (HABP1/p32/gC1qR) in HepG2 cells leads to increased hyaluronan synthesis and cell proliferation by up-regulation of cyclin D1 in AKT-dependent pathway.
Kaul R; Saha P; Saradhi M; Prasad RL; Chatterjee S; Ghosh I; Tyagi RK; Datta K
J Biol Chem; 2012 Jun; 287(23):19750-64. PubMed ID: 22451658
[TBL] [Abstract][Full Text] [Related]
15. Increased hyaluronan levels in HABP1/p32/gC1qR overexpressing HepG2 cells inhibit autophagic vacuolation regulating tumor potency.
Saha P; Ghosh I; Datta K
PLoS One; 2014; 9(7):e103208. PubMed ID: 25061661
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Multifunctional Protein p32 Promotes a Malignant Phenotype in Colorectal Cancer Cells.
Egusquiza-Alvarez CA; Castañeda-Patlán MC; Albarran-Gutierrez S; Gonzalez-Aguilar H; Moreno-Londoño AP; Maldonado V; Melendez-Zajgla J; Robles-Flores M
Front Oncol; 2021; 11():642940. PubMed ID: 34136383
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial protein p32/HAPB1/gC1qR/C1qbp is required for efficient respiratory syncytial virus production.
Hu M; Li HM; Bogoyevitch MA; Jans DA
Biochem Biophys Res Commun; 2017 Aug; 489(4):460-465. PubMed ID: 28576489
[TBL] [Abstract][Full Text] [Related]
18. Antibody neutralization of cell-surface gC1qR/HABP1/SF2-p32 prevents lamellipodia formation and tumorigenesis.
Kim BC; Hwang HJ; An HT; Lee H; Park JS; Hong J; Ko J; Kim C; Lee JS; Ko YG
Oncotarget; 2016 Aug; 7(31):49972-49985. PubMed ID: 27363031
[TBL] [Abstract][Full Text] [Related]
19. Targeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide-guided pro-apoptotic nanoparticles.
Hunt H; Simón-Gracia L; Tobi A; Kotamraju VR; Sharma S; Nigul M; Sugahara KN; Ruoslahti E; Teesalu T
J Control Release; 2017 Aug; 260():142-153. PubMed ID: 28603028
[TBL] [Abstract][Full Text] [Related]
20. The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation.
Petersen-Mahrt SK; Estmer C; Ohrmalm C; Matthews DA; Russell WC; Akusjärvi G
EMBO J; 1999 Feb; 18(4):1014-24. PubMed ID: 10022843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
